Crossref
De-escalating therapy in ductal carcinoma in situ: Evidence for omission of surgery and radiation
European Journal of Surgical Oncology · 2026-05 · 52 · 111607
DOI: 10.1016/j.ejso.2026.111607 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2026-05. Verfasst von Saeeda Yasmin und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yasmin, S., Danish, F., Rabani, A. E., Subhani, F., & Koul, S. S. (2026). De-escalating therapy in ductal carcinoma in situ: Evidence for omission of surgery and radiation. European Journal of Surgical Oncology, 52, 111607. https://doi.org/10.1016/j.ejso.2026.111607
Vancouver
Yasmin S, Danish F, Rabani AE, Subhani F, Koul SS. De-escalating therapy in ductal carcinoma in situ: Evidence for omission of surgery and radiation. European Journal of Surgical Oncology. 2026;52:111607. doi:10.1016/j.ejso.2026.111607
BibTeX
@article{Yasmin2026,
author = {Yasmin, Saeeda and Danish, Fazal-i-Akbar and Rabani, Ahmad Ehsan and Subhani, Fazal-e-Rabi and Koul, Salman Shafi},
title = {De-escalating therapy in ductal carcinoma in situ: Evidence for omission of surgery and radiation},
journal = {European Journal of Surgical Oncology},
year = {2026},
volume = {52},
pages = {111607},
doi = {10.1016/j.ejso.2026.111607}
}
EUVIMED